These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 1751156)

  • 1. A protamine-mediated heparin sensing device.
    Yang VC; Chen W
    ASAIO Trans; 1991; 37(3):M292-4. PubMed ID: 1751156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Versatile, non-clotting-based heparin assay requiring no instrumentation.
    Chen W; Yang VC
    Clin Chem; 1991 Jun; 37(6):832-7. PubMed ID: 2049847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A facile colorimetric protamine titration method.
    Teng CL; Yang VC
    J Lab Clin Med; 1989 Apr; 113(4):498-504. PubMed ID: 2467958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protamine-coated Cuprophan. A potential nonthrombogenic hemodialysis membrane with improved blood compatibility.
    Yang VC; Fu YY; Kim JS
    ASAIO Trans; 1991; 37(3):M229-32. PubMed ID: 1751122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A method for the quantitation of protamine in plasma.
    Yang VC; Fu YY; Teng CL; Ma SC; Shanberge JN
    Thromb Res; 1994 May; 74(4):427-34. PubMed ID: 7521974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A protamine filter for extracorporeal heparin removal. Development, testing, blood compatibility evaluation, and future direction.
    Byun Y; Yun JH; Han IS; Fu Y; Shanberge JN; Yang VC
    ASAIO J; 1995; 41(3):M301-5. PubMed ID: 8573812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategies for improving the functionality of an affinity bioreactor.
    Wang T; Yang Z; Emregul E; David A; Balthasar JP; Liang J; Yang VC
    Int J Pharm; 2005 Dec; 306(1-2):132-41. PubMed ID: 16246511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A protamine filter for extracorporeal blood heparin removal.
    Teng CL; Kim JS; Port FK; Wakefield TW; Till GO; Yang VC
    ASAIO Trans; 1988; 34(3):743-6. PubMed ID: 3196594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Individualized heparin and protamine management improves rotational thromboelastometric parameters and postoperative hemostasis in valve surgery.
    Vonk AB; Veerhoek D; van den Brom CE; van Barneveld LJ; Boer C
    J Cardiothorac Vasc Anesth; 2014 Apr; 28(2):235-41. PubMed ID: 24342152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of a heparin removal device in comparison with protamine after hypothermic cardiopulmonary bypass.
    Tao W; Deyo DJ; Brunston RL; Vertrees RA; Grochoske TL; Zwischenberger JB
    ASAIO J; 1997; 43(5):M825-30. PubMed ID: 9360162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A filter device for the prevention of both heparin- and protamine-induced complications associated with extracorporeal therapy.
    Yang VC; Teng CL; Kim JS
    Biomed Instrum Technol; 1990; 24(6):433-9. PubMed ID: 2261582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rate of protamine administration: its effect on heparin reversal and antithrombin recovery after coronary artery surgery.
    Zaidan JR; Johnson S; Brynes R; Monroe S; Guffin AV
    Anesth Analg; 1986 Apr; 65(4):377-80. PubMed ID: 3954111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of two protocols for heparin neutralization by protamine after cardiopulmonary bypass.
    Arén C; Feddersen K; Rådegran K
    J Thorac Cardiovasc Surg; 1987 Oct; 94(4):539-41. PubMed ID: 3309479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring unfractionated heparin therapy: relationship between eight anti-Xa assays and a protamine titration assay.
    Kitchen S; Theaker J; Preston FE
    Blood Coagul Fibrinolysis; 2000 Mar; 11(2):137-44. PubMed ID: 10759006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Removal of heparin and protamine from plasma.
    Thompson AR; Counts RB
    J Lab Clin Med; 1976 Dec; 88(6):922-9. PubMed ID: 993645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of BAY 41-2272 in the pulmonary hypertension induced by heparin-protamine complex in anaesthetized dogs.
    Freitas CF; Morganti RP; Annichino-Bizzacchi JM; De Nucci G; Antunes E
    Clin Exp Pharmacol Physiol; 2007; 34(1-2):10-4. PubMed ID: 17201729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protamine sulfate causes endothelium-independent vasorelaxation via inducible nitric oxide synthase pathway.
    Takakura K; Mizogami M; Fukuda S
    Can J Anaesth; 2006 Feb; 53(2):162-7. PubMed ID: 16434757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic model of unfractionated heparin during and after cardiopulmonary bypass in cardiac surgery.
    Jia Z; Tian G; Ren Y; Sun Z; Lu W; Hou X
    J Transl Med; 2015 Feb; 13():45. PubMed ID: 25638272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optical sensing of biomedically important polyionic drugs using nano-sized gold particles.
    Jena BK; Raj CR
    Biosens Bioelectron; 2008 Mar; 23(8):1285-90. PubMed ID: 18191561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protamine sulphate inhibits platelet membrane glycoprotein Ib-von Willebrand factor activity.
    Barstad RM; Stephens RW; Hamers MJ; Sakariassen KS
    Thromb Haemost; 2000 Feb; 83(2):334-7. PubMed ID: 10739395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.